Table 1 Demographic and tumor characteristics of patients at time of OAL diagnosis and survival status at end of follow-up period
From: Second primary malignancies after ocular adnexal lymphoma diagnosis
Overall Cohort | SPM Cohort | ||||
|---|---|---|---|---|---|
n | % | n | % | ||
Age Group | 0–49 | 373 | 20.3 | 30 | 10.8 |
50–69 | 769 | 41.9 | 145 | 52 | |
70+ | 692 | 37.7 | 104 | 37.3 | |
Race | White/Unknown | 1504 | 82 | 233 | 83.5 |
Black | 143 | 7.8 | 17 | 6.1 | |
Other | 187 | 10.2 | 29 | 10.4 | |
Gender | Female | 1015 | 55.3 | 141 | 50.5 |
Male | 819 | 44.7 | 138 | 49.5 | |
Primary site | Conjunctiva | 522 | 28.5 | 84 | 30.1 |
Lacrimal Gland | 220 | 12 | 37 | 13.3 | |
Orbit, NOS | 933 | 50.9 | 132 | 47.3 | |
Eyelid | 159 | 8.7 | 26 | 9.3 | |
Laterality | Unilateral | 1693 | 92.3 | 260 | 93.2 |
Bilateral | 119 | 6.5 | 15 | 5.4 | |
Unknown/NA | 22 | 1.2 | 4 | 1.4 | |
Surgery status | Performed | 763 | 41.6 | 110 | 39.4 |
Not Performed | 1047 | 57.1 | 163 | 58.4 | |
Unknown | 24 | 1.3 | 6 | 2.2 | |
Chemotherapy Status | Received | 394 | 21.5 | 59 | 21.1 |
Not Received/Unknown | 1440 | 78.5 | 220 | 78.9 | |
Radiation status | Received | 1179 | 64.3 | 173 | 62 |
Not Received/ Unknown | 655 | 35.7 | 106 | 38 | |
Vital status | Living | 998 | 54.4 | 101 | 36.2 |
Deceased | 836 | 45.6 | 178 | 63.8 | |
Type of cancer | Hodgkin’s - Extranodal | 2 | 0.1 | 0 | 0 |
Plasmacytoma | 22 | 1.2 | 1 | 0.4 | |
Non-Hodgkin’s - Extranodal | 1810 | 98.7 | 278 | 99.6 | |